Sleeping sickness is transmitted by tsetse flies.
More than 60 million people are at risk for sleeping sickness.
The disease is often misdiagnosed in the first stage.
Successful treatment requires a drug that can cross the blood-brain barrier.
MSF is currently responsible for the efficient supply and distribution of all sleeping sickness drugs used in the world today.